Summary
The stock has recorded a trading volume of 12,154 shares,. Its Average Traded Price (ATP) is ₹938.96, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 80 @ ₹944.30.
Epigral has an upper circuit limit of ₹1137.10 and a lower circuit limit of ₹758.10. The total value traded stands at ₹1.14 CR, and the delivery percentage for the day is 40.91%.
The stock is currently traded with a market lot size of 1. Epigral also offers a dividend yield of 0.53%.
Epigral Share Price Chart
Epigral Share Key Metrics
Volume
12154.00
Market Cap
4073.84 CR
LTQ@LTP
80@944.30
ATP
938.96
Var Margin
20.95 %
Circuit Range
758.1-1137.1
Delivery %
40.91 %
Value
1.14 CR
ASM/GSM
No
Market Lot
1
Epigral Resistance and Support
Pivot 948.72
Resistance
First Resistance
959.94
Second Resistance
972.27
Third Resistance
983.49
Support
First Support
936.39
Second Support
925.17
Third Support
912.84
Epigral Shareholding Pattern
View More- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Epigral Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-02 | Quarterly Results |
| 2026-07-27 | Quarterly Results |
| 2026-05-02 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-08-02 | Quarterly Results & Fund Raising |
| 2025-05-05 | Audited Results & Final Dividend |
| 2025-01-27 | Quarterly Results & Interim Dividend |
| 2024-11-09 | Quarterly Results |
| 2024-08-14 | To consider Fund Raising |
| Ex Date | Record Date | |
|---|---|---|
| 2026-06-01 | 2026-06-01 | View More |
Epigral News
Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Epigral reported Q2 FY27 revenue of Rs.752 crores (up 28% YoY) and net profit of Rs.64 crores (up 26% YoY). The growth was driven by a 6% increase in sales volume. The board also approved new capex for Epoxy Resin and MPP projects.
Nov 02 2026 13:59:55
Epigral Ltd - 543332 - Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended On 30.09.2026.
Epigral Limited reported Q2 FY27 cons. revenue of ₹746 crores (up 27% YoY) and net profit of ₹65 crores (up 27% YoY). The company also incorporated a wholly owned subsidiary, Epigral Advanced Materials Limited, for manufacturing chemicals.
Nov 02 2026 13:50:00
Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Credit Rating
CRISIL has assigned revised ratings for Epigral's Rs.1,050 crore bank loan facilities. The long-term rating is set at CRISIL AA/Stable and the short-term rating is CRISIL A1+.
Oct 29 2026 23:03:07
Epigral Ltd - 543332 - Board Meeting Intimation for Meeting Of The Board Of Directors Scheduled To Be Held On Monday, 2Nd November, 2026
Epigral board will meet on 2 November 2026 to review the financial results for Q2 and H1 FY27. The meeting will be held at the registered office.
Oct 26 2026 18:03:00
Epigral Management
| Name | Position |
|---|---|
| Gaurang Trivedi | Company Secretary & Compliance Officer |
| Maulik Patel | Chairman & Managing Director |
Epigral Similar Stocks
Gujarat Alkalies And Chemicals Ltd.
578.95
-10.45 (1.77%)
Laxmi Organic Industries Ltd.
150.81
-3.26 (2.12%)
GHCL Ltd.
454.05
-2.75 (0.60%)
Dhanuka Agritech Ltd.
936.05
4.55 (0.49%)
Chemplast Sanmar Ltd.
248.40
-3.87 (1.53%)
Tatva Chintan Pharma Chem Ltd.
1648.90
-11.90 (0.72%)
Kingfa Science & Technology (India) Ltd.
6227.50
-102.00 (1.61%)
Vishnu Chemicals Ltd.
551.95
2.05 (0.37%)
Epigral FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in EPIGRAL
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC